1
Gary W Cleary, Samir Roy: Transdermal drug-delivery composition. Cygnus Research Corporation, Irell & Manella, March 6, 1990: US04906463 (118 worldwide citation)

A solid state, resilient laminated composite for administering a drug transdermally consisting of a multiplicity of spaced structural laminas of a resilient elastomer, one of which forms the top of the composite, a viscoelastic hydrophobic polymer lamina containing propylene glycol monolaurate inter ...


2
Elie S Nuwayser: Sustained release transdermal drug delivery composition. Biotek, May 22, 1990: US04927687 (37 worldwide citation)

A transdermal drug delivery system useful for the controlled, for example zero order release of one or more drugs to a selected skin area of a user, which system comprises an impervious backing sheet and a face membrane, the backing sheet and membrane secured together to form an intermediate reservo ...


3
Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins: Method and composition for transdermal drug delivery. Acrux DDS, Foley & Lardner, May 7, 2013: US08435944 (12 worldwide citation)

The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatme ...


4

5
FLESCHHUT Jens, FEINAEUGLE Susanne, LAUER Karin: SYSTÈME THÉRAPEUTIQUE TRANSDERMIQUE COMPRENANT DE LA BUPRÉNORPHINE, TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING BUPRENORPHINE. HEXAL, FLESCHHUT Jens, FEINAEUGLE Susanne, LAUER Karin, AECHTER Bernd, May 24, 2012: WO/2012/065740 (3 worldwide citation)

The invention is concerned with a transdermal therapeutic system (TTS) comprising buprenorphine and a method of manufacturing such a TTS. The transdermal therapeutic system is used for the transdermal administration of buprenorphine and analogues thereof. In particular, the invention relates to the ...


6
Di, Pietro Tony, Humberstone Andrew, Gonda Igor, Watkinson Adam, Robinson Monique, Setiawan Kerrie, Stone Carolyn, Wilkins Nina: Method and composition for transdermal drug delivery. Acrux Dds, Di, Pietro Tony, Humberstone Andrew, Gonda Igor, Watkinson Adam, Robinson Monique, Setiawan Kerrie, Stone Carolyn, Wilkins Nina, FREEHILLS PATENT AND TRADE MARK ATTORNEYS, December 7, 2006: WO/2006/128255 (2 worldwide citation)

The invention is a transdermal drug delivery composition of at least one physiologically active agent (e.g. buspirone or fentanyl or androgens such as testosterone), at least one volatile solvent (e.g. isopropanol or ethanol), and at least one viscosity modulating agent (e.g. PVP), preferably with a ...


7
Mou Ying Fu Lu, Ho Wah Hui: Transdermal drug delivery composition. Abbott Laboratories, Mou Ying Fu Lu, Ho Wah Hui, DANCKERS Andreas M, August 9, 1990: WO/1990/008553 (1 worldwide citation)

Pharmaceutical compositions having enhanced membrane permeability that comprise a therapeutically active ingredient, a penetration enhancer, a solubilizing agent and a solvent vehicle. These compositions are useful in oral and transdermal applications.


8
James B McClain, Charles Douglas Taylor, Wenda C Carlyle: Macrolide dosage forms. Micell Technologies, Lerner David Littenberg Krumholz & Mentlik, May 2, 2017: US09636309

Provided is a drug delivery composition comprising at least one polymer and at least one active agent; wherein the active agent is present in crystalline form on at least one region of an outer surface of the composition and wherein active agent surface content is adjusted to provide a selected acti ...


9
Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins: Method and composition for transdermal drug delivery. Acrux DDS, Foley & Lardner, March 31, 2015: US08993520

The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatme ...


10
Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins: Method and composition for transdermal drug delivery. ACRUX DDS, Foley & Lardner, November 10, 2015: US09180194

The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatme ...